Homeopathic Topical Cream Recalled for Manufacturing Process Deviations
DISCOVERY PHARMA LLC voluntarily recalled 21,892 tubes of Conzerol zero molluscum contagiosum topical cream distributed in California, Florida, and Washington due to current good manufacturing practice deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary Class II recall with no reported illnesses or injuries. The recall was initiated due to current good manufacturing practice deviations, which constitute manufacturing process violations. Without reported harm or a specifically named safety hazard, this qualifies as a moderate-severity precautionary recall.
Plain-English summary
Conzerol zero molluscum contagiosum is a homeopathic topical cream (0.78 oz/22g tubes) manufactured by DISCOVERY PHARMA LLC. The product is intended as a topical treatment for molluscum contagiosum and was distributed in California, Florida, and Washington.
The FDA classified this recall as Class II and issued it in response to current good manufacturing practice (CGMP) deviations identified in the product's manufacturing process. The firm initiated the recall voluntarily in November 2022.
The recall affects 21,892 tubes with lot numbers 22123 (expiring January 2024) and 21732 (expiring July 2023). Consumers who have purchased this product should discontinue use and consult with their healthcare provider or pharmacist if they have concerns about their use of the product.
The recalled product
- Product
- Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland
- Manufacturer
- DISCOVERY PHARMA LLC
- Category
- Drug — Topical
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 22123 Exp. 01/2024
- 21732 Exp. 07/2023
Distribution
Distributed in 3 states:
- CA
- FL
- WA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27